Key result
Endothelial dysfunction is significantly associated with the development of long COVID-19 and may contribute to the future development of chronic kidney disease and cardiovascular disease.
Why the study?
Over 65 million individuals suffer from long COVID-19, but its underlying causes remain largely unknown.
Does endothelial dysfunction in long COVID-19 contribute to the future development of CKD and ASCVD?
Population
Patients with long COVID-19
Design
Review
Authors
Loading...
Endothelial dysfunction associates with long COVID-19 and ASCVD biomarkers; leaves open whether targeting it alters outcomes.
Does endothelial dysfunction in long COVID-19 contribute to the future development of CKD and ASCVD?
Endothelial dysfunction in long COVID-19 may be a crucial mechanism linking the condition to future risks of chronic kidney disease and atherosclerotic cardiovascular disease.
Yanai et al. (2024) conducted a review in Long COVID-19. Endothelial dysfunction was evaluated. Endothelial dysfunction is significantly associated with the development of long COVID-19 and may contribute to the future development of chronic kidney disease and cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: